The Janssen Pharmaceutical Companies of Johnson & Johnson’s ENSEMBLE 2 Vaccine Clinical Trial

Henry Ford Health System is a study site for the Johnson & Johnson COVID-19 ENSEMBLE 2 vaccine clinical trial. This vaccine trial will evaluate the safety and efficacy of Janssen’s investigational vaccine for the prevention of COVID-19 in adult participants.


This vaccine requires two doses. We are currently enrolling volunteers ages 60 and above. If you are interested in volunteering, please click on this survey link.


Henry Ford Health System is registered and posted as a Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research trial participant on clinicaltrials.gov identifier: NCT04505722